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Abstract
Mitochondrial Ca2+ controls numerous cell functions, such as energy metabolism, reactive
oxygen species generation, spatiotemporal dynamics of Ca2+ signaling, cell growth and death in
various cell types including neurons. Mitochondrial Ca2+ accumulation is mainly mediated by the
mitochondrial Ca2+ uniporter (MCU), but recent reports also indicate that mitochondrial Ca2+influx mechanisms are regulated not only by MCU, but also by multiple channels/transporters.
We previously reported that ryanodine receptor (RyR), which is a one of the main Ca 2+-release
channels at endoplasmic/sarcoplasmic reticulum (SR/ER) in excitable cells, is expressed at the
mitochondrial inner membrane (IMM) and serves as a part of the Ca2+ uptake mechanism in
cardiomyocytes. Although RyR is also expressed in neuronal cells and works as a Ca2+-release
channel at ER, it has not been well investigated whether neuronal mitochondria possess RyR
and, if so, whether this mitochondrial RyR has physiological functions in neuronal cells. Here we
show that neuronal mitochondria express RyR at IMM and accumulate Ca2+ through this
channel in response to cytosolic Ca2+ elevation, which is similar to what we observed in another
excitable cell-type, cardiomyocytes. In addition, the RyR blockers dantrolene or ryanodine
significantly inhibits mitochondrial Ca2+ uptake in permeabilized striatal neurons. Taken
together, we identify RyR as an additional mitochondrial Ca2+ uptake mechanism in response to

the elevation of [Ca2+]c in neurons, suggesting that this channel may play a critical role in
mitochondrial Ca2+-mediated functions such as energy metabolism.

Introduction
Mitochondria play an important role in shaping the intracellular Ca2+ concentration as they can
take up Ca2+ in response to physiological changes in the cytosolic Ca2+ concentration ([Ca2+]c) in
various cell-types/tissues including neurons [7,10,24]. Mitochondrial Ca2+ accumulation was first
recognized as an important mechanism for the acceleration of oxidative phosphorylation and
electron transport chain activity, which results in the stimulation of ATP synthesis [12]. In
addition, mitochondrial dysfunction and the loss of cellular Ca2+ homeostasis are frequently
observed together in pathophysiological conditions such as neuronal excitotoxicity, apoptosis
and neurodegenerative disorders [8]. However, the detailed mechanisms of how altered
mitochondrial Ca2+ handling and/or mitochondrial dysfunction affect these neurological
pathogenesis are not yet fully understood.
Mitochondrial Ca2+ influx was originally considered as a single transport
mechanism through mitochondrial Ca2+ uniporter (MCU) which can be inhibited by ruthenium
red and lanthanides (see reviews [7,24]). However, the molecular identities responsible for
mitochondrial Ca2+ accumulation have remained an unsolved question until very recently.
Recently, several groups have discovered the molecular identity of MCU and its regulatory
proteins and confirmed it as the main mitochondrial Ca2+ uptake mechanism (see
reviews[19,24]). Although in these studies MCU was confirmed as the most dominant Ca2+ influx
mechanism, previous studies have identified additional Ca2+ uptake pathways, which display
different physiological and pharmacological characteristics from MCU theory (see reviews
[7,24]).
Among these studies, we reported that ryanodine receptor (RyR) is one
of the mitochondrial Ca2+ influx mechanisms in another excitable cell-type, cardiomyocytes,
termed mRyR (mitochondrial RyR) [2,3] (see also reviews [24,25]). Our group first identified that
a low level of RyR is expressed in the mitochondrial inner membrane (IMM) in cardiomyocytes

through a combination of biochemical, cell biological and electrophysiological experiments.
Since cardiac mRyR exhibits a bell-shaped Ca2+-dependent activation (bimodal activation) in the
physiological range of [Ca2+]c, this unique property places mRyR as an ideal candidate for
sequestering Ca2+ quickly and transiently during physiological [Ca2+]c oscillation in excitable
cells. In addition, using not only native cardiomyocytes, but also RyR overexpression/knock-out
in cultured cardiac myoblasts and knock-out mouse hearts, we showed that the molecular
identity of mRyR is possibly a skeletal-muscle type-isoform RyR type 1 (RyR1) and is required
for Ca2+-dependent acceleration of ATP production in cardiomyocytes even though the
expression level is much lower than RyR2 which is the main RyR isoform expressed in cardiac
sarcoplasmic reticulum (SR) /endoplasmic reticulum (ER) [3,23].
Although RyR is expressed [9,11,31] in the brain and serves as a Ca2+-release channel
of the intracellular Ca2+ store (ER) in addition to inositol 1,4,5-trisphosphate (IP3) receptors
[15,17,18], the interaction of between the RyR expression and mitochondrial functions under
physiological and pathophysiological conditions in brain has been completely unknown.
Therefore, the objective of this study was to investigate the possibility whether neuronal
mitochondria possess mRyR similar to cardiomyocytes and to assess if mRyR takes part in the
mitochondrial Ca2+ influx mechanism. Our finding suggests that RyR is expressed at IMM and
takes up Ca2+ into mitochondria in response to [Ca2+]c elevations.

Materials and Methods
An expanded Material and Methods section is available in the online supplementary file.
Reagents and antibodies
All reagents and antibodies were purchased from Sigma-Aldrich Corporation (St. Louis, MO)
unless otherwise indicated.

Cells
All procedures involving animal use were in accordance with the NIH Guide for the Care and
Use of Laboratory Animals, and were approved by the University Committee on Animal
Resources. Primary striatal neurons were prepared from Sprague-Dawley rat embryos
(embryonic day 18) [1].
Preparation of rat brain mitochondria and mitochondrial subfractions
Mitochondria-enriched protein fractions and mitochondrial subfractions were prepared using
differential centrifugation [3,23].
Fluorescence microscopy
Localization of RyR was observed in live or fixed cultured striatal neurons using confocal
microscopy (Leica, Heidelberg Germany). For live cells, RyR, SR/ER and mitochondria were
labeled with boron-dipyrromethene (Bodipy)-conjugated ryanodine (Bodipy-Ry), Bodipyconjugated sarco/endoplasmic Ca2+-ATPase (SERCA) inhibitor thapsigargin (Bodipy-Thap) and
Mitotracker Deep Red (MTR) (Molecular Probes, Eugene, OR), respectively. The pre-treatment
of unlabeled ryanodine completely abolished the Bodipy-Ry staining, confirmed that Bodipy-Ry
specifically binds to RyRs in live striatal neurons (Supplementary Fig.1). For time-lapse studies,
live cell images were collected by TILL system (TILL Photonics, München, Germany). For
detection of RyR in fixed striatal neurons, cells were probed with primary antibodies against
RyR (Santa Cruz biotechnology, Santa Cruz, CA) and cytochrome c oxidase (Cox) (for labeling
mitochondria) (Molecular Probes) followed by fluorescence-conjugated secondary antibodies.
Scatter 2D plots of pixel intensities and Pearson’s correlation coefficient were obtained by
Image J software (NIH) [23].
Measurements of cytosolic and mitochondrial Ca2+ concentration
[Ca2+]c in permeabilized striatal neurons was measured by Ca2+ indicator Fura-2 with a
fluorescent microscope (TILL Photonics) [26]. For mitochondrial Ca2+ concentration ([Ca2+]m)

measurements, cells were skinned by saponin and then stained by an acetoxymethyl (AM) ester
form of Fura-2 or Rhod-2 [26]. Fura-2 calibration was performed as previously reported [1].
[3H]ryanodine binding
[3H]ryanodine binding assays were performed as we previously described [3].
Data and statistical analysis
All results are shown as mean standard error or otherwise indicated. Unpaired Student’s t-test
was performed. Statistical significance was set as a p value of <0.05.

Results
Dantrolene and Ryanodine block mitochondrial Ca2+ uptake in striated neurons.
To test whether RyR is involved in the mitochondrial Ca2+ uptake mechanism in neurons, the
changes in [Ca2+]m in response to [Ca2+]c elevation were measured in permeabilized neurons in
the presence and absence of a RyR blocker, dantrolene using Fura-2 [3]. First, we stimulated
the cells with IP3 and mobilized IP3 receptor-based SR Ca2+ release. Because RyRs were
expressed at ER [3,11,21], this protocol is enable to match the magnitude of cytosolic Ca2+
transient in the presence and absence of dantrolene [23]. We confirmed that the application of
10 µM IP3 induced Ca2+ release from intracellular stores, resulted in an increase of the [Ca2+]c
(from 108  11.4 to 550  47.3 nM) (Fig.1A). We also confirmed that magnitude of Ca2+ release
from ER by IP3 treatment did not changed significantly changed in the presence or in the
absence of dantrolene (490  51.2 versus 550  47.3 nM, P=1.00). Under this experimental
condition, we next observed the changes in [Ca2+]m in response to IP3 treatment (Fig.1B). We
confirmed that the application of IP3 quickly increased [Ca2+]m (from 110  0.6 to 700  59.6 nM),
but 10-min pretreatment of dantrolene significantly inhibited IP3-induced increase in [Ca2+]m. In
addition, the IP3-induced increase in [Ca2+]m (from 90  7.8 to 250  19.6 nM) partially recovered
after washing out dantrolene, suggesting that this inhibitory effect by dantrolene is reversible.

We also observed that the treatment of another RyR blocker, ryanodine, also significantly
inhibited mitochondrial Ca2+ uptake in response to the application of Ca2+ into the extracellular
solution (Supplementary Fig.2). These results indicate that in neurons, RyR is involved in the
mitochondrial Ca2+ uptake mechanism.
RyR is expressed in the inner mitochondrial membrane in neurons
We next tested whether RyR is expressed in mitochondria (i.e. mRyR) using biochemical
approaches. Using specific antibody against RyR, we confirmed that RyR was detectable in
mitochondria-enriched protein fractionation obtained from whole brain (Fig.2A and B). Because
RyR is mainly expressed in SR/ER, the purity of our mitochondria-enriched protein fractionation
was evaluated by detection of voltage-dependent anion channel (VDAC) and calnexin by
Western blotting as mitochondrial and ER/SR markers, respectively [3]. The mitochondriaenriched protein fractionation obtained from whole brain showed that RyR is found in both in
cytosolic (including SR)- and mitochondria-enriched protein fraction (Fig.1B). To determine the
submitochondrial localization of RyR in brain mitochondria, the IMM-enriched proteins were
separated by osmotic shock from the outer mitochondrial membrane (OMM) and the contact site
(CS) fractions. Separation of OMM-, CS-, and IMM-enriched fractions was confirmed by the
detection of the levels of marker proteins for IMM and OMM, adenine-nucleotide translocator
(ANT) and VDAC, respectively (Fig.2B). RyR was detectable mainly from IMM, which is similar
to the results we reported in cardiomyocytes [3].
Expression of RyR in mitochondria was further confirmed in cultured live striatal neurons.
First, we labeled RyR with fluorescence-dye (Bodipy) conjugated ryanodine (Bodipy-Ry) in live
cultured striatal neurons (Fig.2C). Bodipy-Ry showed a mesh-like staining pattern with
punctuate staining region. We also found that punctuate staining regions of Bodipy-Ry were
colocalized with MTR staining, suggesting that RyR is partially expressed in mitochondria. Timelapse imaging showed that these spots moved, which further verified that this punctuate
structures were indeed mitochondria (Supplementary Fig.3). For comparison, we also stained

the neuron cells with Bodipy-Thap for labeling ER. The Bodipy-Thap signals showed almost no
colocalization with MTR (Fig.2C). Scatter 2D plots of pixel intensities in red (MTR) and green
(Bodipys) channels indicated that the cells stained by Bodipy-Ry possessed higher amount of
co-localized pixels (yellow in segment 3 in Fig.2C) compared to those observed in the cells
stained by Bodipy-Thap. We next quantitatively assessed an efficiency of the mitochondrial
colocalization by calculating the values of Pearson's correlation [23] (Fig.2C). The Pearson’s
value for Bodipy-Ry-MTR staining was higher than that in Bodipy-Thap-MTR staining (0.716 vs
0.322 in Fig.2C), suggesting that RyR was not only localized at ER, but also partially localized at
mitochondria. In contrast to neurons, no colocalization of the Bodipy-Ry and MTR was observed
in glia cells (Supplementary Fig.4) (Pearson’s value=0.276). In addition, red-range Bodipy-Ry
(Bodipy-TR-Ry) was almost colocalized with Bodipy-Thap, suggesting that RyR is expressed in
ER, but not in mitochondria in glia cells (Pearson’s value=0.828).
Expression of RyR in mitochondria was further confirmed by immunocytochemistry using
the same RyR-specific antibody used in Western blotting (Fig.2D, see also Fig.2A and B).
Confocal analysis revealed a mesh-like staining pattern with punctuate staining region for RyR.
Double labeling against Cox (an IMM protein) confirmed that RyR partially localized at
mitochondrial localization (see fluorescence profiles in Fig.2D).
Characterization of mRyR in brain mitochondria
Finally, we further characterized the neuronal mRyR using [3H]ryanodine binding assays (Fig.3).
[3H]ryanodine bound with high affinity to isolated brain mitochondria in [3H]ryanodineconcentration dependent manner (Fig.3A). The apparent affinity (Kd) of [3H]ryanodine binding
was 8.5 nM in the presence of 20 µM Ca2+ and the maximal number of binding sites (Bmax) was
103 fmol/ mg protein obtained by Scatchard plot (Fig.3B). We next investigated modulation of
[3H]ryanodine binding by Ca2+ and caffeine, which are well known modulators of ryanodine
binding to RyR of ER/SR [3]. Indeed, brain mitochondria showed both Ca2+- and caffeinesensitive manner in [3H]ryanodine binding (Fig.3C). We found a bell-shaped curve for Ca2+

dependence with maximal [3H]ryanodine binding occurring at pCa 5.2. In addition, application of
caffeine increased [3H]ryanodine binding (Fig.3C). This increase in [3H]ryanodine binding by
caffeine was also Ca2+-dependent. Maximal increase (50%) in [3H]ryanodine binding was
obtained at pCa 6.

Discussion
In the present study, we report the molecular and functional identification of mRyR in neuron.
First, we showed in cultured primary cells that neuronal mitochondrial Ca2+ accumulation is
sensitive to both ryanodine and dantrolene (Fig.1 and Supplementary Fig.2). Second, using
brain mitochondria and cultured primary cells, we found that RyR is not only expressed in ER,
but also in mitochondria possibly at IMM (Fig.2). Third, we characterized neuronal mRyR and
found that the properties of ryanodine binding are similar to those we observed in cardiac mRyR
[3] (Fig.3). These results indicate that, in addition to MCU, RyR is involved in the mitochondrial
Ca2+ influx mechanism in neurons, similar to our previous observation in another excitable celltype, cardiomyocytes [3].
Our finding that neurons express mRyR adds a new component to the complexity of
mitochondrial Ca2+ uptake in neuron. The prevailing view is that the ruthenium red-inhibitive
MCU is exclusively responsible for mitochondrial Ca2+ influx (see review [19]). However, the
growing evidence also advances the idea that multiple Ca2+ influx mechanisms coexist,
including our findings of mRyR [24,25]. Indeed, we showed that ryanodine or dantrolene
treatment significantly inhibited the mitochondrial Ca2+ accumulation in neuron, but did not
completely abolish, suggesting that other ion channel/transporters are engaged in mitochondrial
Ca2+ mechanism and mRyR serves as a part of this mechanism (Fig.1 and Supplementary
Fig.2). Elucidation of the unique biophysical characteristics and physiological functions for each
Ca2+ influx mechanism is significant for our understanding of mitochondrial Ca2+ signaling in
regulating physiology and pathophysiology in excitable cells including neurons. Recent studies

revealed that dantrolene treatment is significantly protective from cytotoxicity in neurons and/or
the progression of neurodegenerative disorders [5,14,22], suggesting the potential importance
of RyR in neuronal cell death signaling under the pathophysiological conditions. Future studies
will address our next hypothesis: mRyR in neurons is involved in the regulation of ATP
production through Ca2+ accumulation, as we previously showed in the heart, [3,23] and how
mRyR expression levels and functions might be altered under pathophysiological conditions.
In brain, all three RyR subtypes (RyR1, 2 and 3) are expressed [9,11,27,31]. However,
in our biochemical and cell biological studies (Figs.2&3), we used RyR-isoform non-specific
antibody and Bodipy-Ry to identify mRyR in neuronal cells, which could not distinguish which
isoform(s) is (are) expressed in mitochondria. We previously reported that RyR2 is expressed at
SR and RyR1 can be expressed only in mitochondria, but not in SR in cardiac cells, suggesting
that the molecular identity of mRyR in cardiomyocytes is RyR1 [3,23].

RyR2 is not only

expressed in SR/ER, but also at the plasma membrane [20] or in the Golgi complex [6], which
supports our idea of RyR isoform-dependent subcellular distribution/retention. Thus, it is a
reasonable idea that multiple RyR subtypes are expressed in a single neuronal cell and each
isoform has a different subcellular localization as shown in cardiomyocytes. Further studies will
be required to precisely identify the isoform(s) of mRyR in neuron (whether neuronal mRyR is
RyR1 or not) using genetic knockdown or overexpression as we performed in cardiac cells
[3,23].
In addition, RyR subtypes show different spatial and temporal expression patterns
among various brain regions [9,11,27,31]. The main RyR isoform is RyR2 [15,17,18] , which is
evenly expressed throughout the brain at relatively high levels. RyR3 is also ubiquitously
expressed in the brain at lower levels compared to RyR2 [9,11,31] and serves as a part of the
Ca2+-release mechanism in ER [21,29]. Interestingly, skeletal-muscle type isoform RyR1 is
expressed in the brain [11,31], particularly at the cerebellum, cortex, and hippocampus [16,30],

but the physiological relevance of the uneven distribution pattern of RyR1 is completely
unknown. The brain is an organ with a high

metabolic demand and energy availability

determines the power and speed of the neuronal transmission system. Since the cerebellum,
cortex, and hippocampus have a high number of synapses [28] and use ATP to accelerate
synaptic transmission, act as a neurotransmitter [4], generate action potential, and maintain
resting potentials [13]: it is a feasible idea that the neuronal cells in these regions possess an
additional molecular mechanism to enhance the efficiency of Ca2+-dependent ATP production in
mitochondria (mRyR), similar to cardiomyocytes. Further studies will address the different
expression levels of mRyR between various brain regions and also will clarify whether the
mRyR expression pattern in the brain has a correlation to the mitochondrial bioenergetics and
cellular energy demands in the central nervous system.

Conclusion
Our studies show the molecular and functional identification of mRyR in neuronal
mitochondria. Our results suggest that mRyR may function to sequester Ca2+ to mitochondria in
response to the elevation of [Ca2+]c in neurons.
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Figure Legends

Fig.1. Dantrolene inhibits mitochondrial Ca2+ uptake induced by IP3-mediated Ca2+ release
from the ER. A. Representative time course of the changes in [Ca2+]c in response to 10 µM IP3
treatment in saponin-permeabilized striatal neurons. First, permeabilized cells were exposed to
IP3 to evoke first [Ca2+]c elevation. Then IP3 was washed out and the cells were treated with 10
µM dantrolene (Dan) for 10 minutes, followed by a second exposure to IP3. B. Representative
time course of the changes in [Ca2+]m in response to 10 µM IP3 treatment in saponinpermeabilized striatal neurons under the same protocols in A.

Fig.2. RyR is expressed in neuronal mitochondria.
A. Representative Western blots of mitochondria-enriched fractions from rat liver and brain
(from three different preparations). B. Representative Western blots of mitochondria-enriched
fraction and mitochondrial subfractions from rat brain. Cytosolic/ER-protein enriched fraction
from rat brain and mitochondria-enriched fraction from rat heart were shown as a comparison. C.
Labeling of RyR or SERCA in live striatal neurons using Bodipy-Ry or Bodipy-Thap, respectively.
Images were taken from the areas of neurites. Top: Neurons were also labeled with MTR (red
emission) to visualize the localizations of mitochondria. Color scatter plottings obtained from the
representative pictures at left were shown in right. Region 1 and 2 pixels represent signal in
channel 1 (green) or 2 (Red) only, respectively and region 3 represents co-localized pixels.
Scale bars, 5 m. D. Immunocytochemical detection of RyR. Images were taken from the areas

of neurites. The fluorescence profile from a dot square region at each image is shown at the
bottom. Arrows show the location of peak fluorescence. Scale bars, 20 m. A.U., Arbitrary unit.

Fig.3. [3H]ryanodine binding assay in isolated brain mitochondria. A. [3H]ryanodine binds
to isolated mitochondria from rat brain with high affinity. B. Scatchard plot of [3H]ryanodine
binding. C. [3H]ryanodine binding in various free Ca2+ concentration in the presence (gray
circles) or in the absence (black squares) of 20 mM caffeine. p<0.05, compared to the control in
each pCa.
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